ATC Group: A08AB Peripherally acting antiobesity products

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A08AB in the ATC hierarchy

Group A08AB contents

Code
Title

Active ingredients in A08AB

Active Ingredient
Description

Orlistat is a potent, specific and long-acting inhibitor of gastrointestinal lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine site of the gastric and pancreatic lipases. The inactivated enzyme is thus unavailable to hydrolyse dietary fat, in the form of triglycerides, into absorbable free fatty acids and monoglycerides.

Related product monographs

Title
Information Source
Document Type
 
FDA, National Drug Code (US)
MPI, US: SPL/PLR
European Medicines Agency (EU)
MPI, EU: SmPC